共 50 条
- [4] Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma [J]. FUTURE ONCOLOGY, 2011, 7 (10) : 1149 - 1167
- [7] Salvigenin Suppresses Hepatocellular Carcinoma Glycolysis and Chemoresistance Through Inactivating the PI3K/AKT/GSK-3β Pathway [J]. Applied Biochemistry and Biotechnology, 2023, 195 : 5217 - 5237